Clark Estates »

Catalyst Pharmaceutical Partners shares owned by Clark Estates

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Clark Estates from 13F filings

Historical chart of Clark Estates investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Clark Estates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Clark Estates

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.7M 231k 15.94
2023-12-31 $3.3M 198k 16.81
2023-09-30 $2.2M 188k 11.69

More positions owned by Clark Estates

Ea Series Trust Euclidean Fundam (ECML)
Kenvue (KVUE)
Dun & Bradstreet Hldgs (DNB)
Philip Morris International (PM)
Haleon Spon Ads (HLN)
Medtronic SHS (MDT)
Fiserv (FI)
Ge Healthcare Technologies I Common Stock (GEHC)
Smith & Nephew Spdn Adr New (SNN)
L3harris Technologies (LHX)
Unilever Spon Adr New (UL)
Shattuck Labs (STTK)
Bausch Plus Lomb Corp Common Shares (BLCO)
Alphabet Cap Stk Cl A (GOOGL)
Solventum Corp Com Shs

View all positions for Clark Estates

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners